including cash flow and revenue forecasting, modeling, and more.
enabling executives to make strategic decisions.
including consolidations, data room management, sell-side analytics, and more.
Consolidated 2022 annual budget for $130M gross expense BioPharma company.
Consolidated headcount and operating expense requests from P&L owners.
Loaded income statement and cash flow data into Workday Adaptive Planning and prepared reports for senior management.
Forecasted revenue and expenses, conducted variance analysis, and adjusted operations to remain within strategic plan.
Consolidated and communicated financials to executive team.
Structured revenue contracts that increased revenue and cash forecast accuracy.
Managed monthly close and forecast process for $980M gross annual expense business unit.
Developed annual financial plan and 3-year outlook for business unit.
Translated $50M term software annual operating plan from ASC 605 to ASC 606.
Analyzed and consolidated revenue and cost of revenue data from multiple systems.
Built strategic business models that enabled executives to define new business strategy and operating plan with PE owners.
Created full model including cash flow and P&L impact of a $1.5M annual revenue business unit to determine if there was a strategic reason to sell business unit.
Managed data room for company with multiple clinics across several states.